EventsThe 1st International E-Conference on Antioxidants in Health and Disease
Published
This submission belongs to the session S3. The Biology of Natural Products in Disease Pathophysiology: Mechanisms of Action of the event The 1st International E-Conference on Antioxidants in Health and Disease
Published date
03 Dec, 2020
Citation
Mihalis I Panagiotidis, Melina Mitsiogianni, Aglaia Pappa, Rodrigo Franco, Dimitrios T Trafalis, Sotiris Kyriakou, Cruciferous Vegetables-Based Isothiocyanate Compounds as Novel Epigenetic Modulators in Human Malignant Melanoma, in Proceedings of The 1st International E-Conference on Antioxidants in Health and Disease, 1 December–15 December 2020, MDPI: Basel, Switzerland, doi: 10.3390/CAHD2020-08892
Share
Email
Facebook
Twitter
LinkedIn

Cruciferous Vegetables-Based Isothiocyanate Compounds as Novel Epigenetic Modulators in Human Malignant Melanoma

image
image
1. Department of Applied Sciences, Northumbria University, Newcastle Upon Tyne, NE1 8ST, UK
2. Department of Electron Microscopy & Molecular Pathology, Cyprus Institute of Neurology & Genetics, Nicosia, 2371, Cyprus
3. Laboratory of Pharmacology, Clinical Pharmacology Unit, Medical School, National and Kapodistrian University of Athens, Athens, 11527, Greece
4. School of Veterinary Medicine & Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, NE 68583, USA
5. Department of Molecular Biology & Genetics, Democritus University of Thrace, Alexandroupolis, 68100, Greece
6. Department of Electron Microscopy & Molecular Pathology, Cyprus Institute of Neurology & Genetics, Nicosia, 2371, Cyprus, Cyprus
Abstract

Among the various types of dietary agents, isothiocyanates (ITCs) have raised the scientific interest with their unique properties, against disease development, including modulation of the epigenetic machinery. In the context of malignant melanoma, our research efforts have aimed to understand how ITCs induce cell death by interacting with the epigenetic machinery and thus leading to inhibition of tumour growth. For this purpose, we have utilised an experimental in vitro model of human malignant melanoma consisting of normal keratinocytes as well as primary and metastatic melanoma cell lines. In this model, specific ITCs [e.g. Sulforaphane (SFN), Iberin (IBN), Allyl Isothiocyanate (AITC), Benzyl Isothiocyanate (BITC) and Phenethyl Isothiocyanate (PEITC)] were examined for their ability to influence specific histone acetylation and methylation marks, as a potential epigenetic therapeutic strategy against melanoma. Overall, we report that all ITCs inhibited melanoma cell proliferation and influenced acetylation and methylation status of specific lysine residues on H3 and H4 by modulating the expression of various histone acetyl transferases (HATs), histone deacetylases (HDACs) and histone methyl transferases (HMTs), in malignant melanoma cells. Our data highlight novel insights on SFN, IBN, AITC, BITC and PEITC interaction with components of the histone regulatory machinery, to exert their anticancer action in malignant melanoma.

Keywords
isothiocyanates
epigenetic
apoptosis
melanoma
Manuscript
Oral Presentation
Poster
038276 The First International E-Conference on Antioxidants in Health & Disease- Mihalis Panagiotidis.pdf
Personalized Nutrition Plans based on Measurement of Specific Redox Biomarkers in Human Blood
Modelling of Protein-Polyphenol Interactions